Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
24.37
+1.51 (6.61%)
At close: Feb 6, 2026, 4:00 PM EST
22.00
-2.37 (-9.72%)
After-hours: Feb 6, 2026, 5:41 PM EST
Tectonic Therapeutic Market Cap
Tectonic Therapeutic has a market cap or net worth of $456.12 million as of February 6, 2026. Its market cap has decreased by -26.74% in one year.
Market Cap
456.12M
Enterprise Value
188.92M
1-Year Change
-26.74%
Ranking
Category
Stock Price
$24.37
Market Cap Chart
Since June 21, 2024, Tectonic Therapeutic's market cap has increased from $250.63M to $456.12M, an increase of 81.99%. That is a compound annual growth rate of 44.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 456.12M | 16.83% |
| Dec 31, 2025 | 390.42M | -42.68% |
| Dec 31, 2024 | 681.13M | 171.77% |
| Jun 21, 2024 | 250.63M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 454.99M |
| vTv Therapeutics | 451.81M |
| Vanda Pharmaceuticals | 449.13M |
| Niagen Bioscience | 443.29M |
| Absci | 437.58M |
| Kyverna Therapeutics | 435.33M |
| PureTech Health | 434.32M |
| Assembly Biosciences | 428.09M |